论文信息 - Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3 - 字舞流文

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3

J. Pignon | C. Chouaid | E. Quoix | É. Dansin | J. Madelaine | V. Westeel | F. Morin | J. Cadranel | I. Borget | B. Coudert | C. Daniel | S. Friard | A. Madroszyk | J. Cadranel | Bruno Coudert | Isabelle Borget | Catherine Daniel | Christos Chouaid | B. Coudert